Here's a complete list of 10 top-performing Canadian marijuana stocks this year. After the list, we'll show you the best way to profit from Canada's 2018 legalization, which could boost sales in the country by 400% in the next four years…
|Canadian Cannabis Stock||Current Price||2017 Gain (as of Oct. 12)|
|Amfil Technologies Inc.|
|Newstrike Resources Ltd.|
|Cavan Ventures Inc.|
|Cronos Group Inc.|
|Isodiol International Inc.|
|Revive Therapeutics Ltd.|
|CTT Pharmaceutical Holdings Inc.|
|ABcann Global Corp.|
Pot Profits: Forget Jeff Sessions! These Five Canadian Pot Stocks Are Set to Skyrocket. Click Here…
Amfil Technologies is an Ontario-based company that acquires small businesses across the construction and marijuana industries. The biggest month for the stock was April, when AMFE surged 166.7%, from $0.03 to $0.08, after the firm announced a partnership with a hydroponics manufacturer.
On April 21, Amfil announced it will be teaming up with Roto-Gro World Wide Inc. – which sells hydroponic garden systems to marijuana growers – to develop and distribute the GROzone EcoPr03 Antimicrobial System. This is Amfil's device that kills harmful organisms during the hydroponic growing process, allowing cannabis to grow in water rather than traditional soil.
Amfil's entrance into the high-growth hydroponics industry is largely what's driven AMFE stock higher this year. According to Manifest Mind LLC, the value of all hydroponically grown plants around the world will climb to $24 billion next year. That's up 20.3% from 2015.
While AMFE might be a tempting way to profit from the hydroponics industry, Money Morning Director of Technology and Venture Capital Research – and marijuana expert – Michael A. Robinson has an even better stock.
This company – which began as a lawn and garden company 150 years ago – was one of the first to invest in the potential of hydroponics. In 2015, it purchased a hydroponics firm in what was then the garden company's biggest acquisition in 17 years.
Media outlets considered the acquisition extremely risky, but Michael's recommendation has made investors a killing. According to a Bloomberg report, this firm's revenue just from its hydroponics business is set to grow 300% in the next few years.
Although it's not a penny stock, Michael believes this company could end up being one of the top-performing stocks in the hydroponics industry…